The 15th Anniversary of Pharmaceutics—Aptamers as Novel Therapeutics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 871
Special Issue Editors
Interests: biomaterials-based local delivery approaches for regeneration and treatment of inflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleague,
Aptamers are nucleotide-based molecules that can be used as antibody alternatives in analytical, diagnostic, and therapeutic applications. Aptamers can be selected from large libraries to bind a specific target, including targets that are traditionally difficult for other affinity reagents, such as antibodies. Together with their stability, the ease and reproducibility of synthesis render this molecule class the therapeutic agent of the future.
This Special Issue encompasses translational research into the effectivity as well as promises of, and hurdles to be taken for, aptamers as targeting ligands and therapeutic molecules in a variety of diseases.
Dr. Laura B. Creemers
Dr. Jaqueline Lourdes Rios
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
